Oncolys BioPharma Inc.

Direct answer

Oncolys BioPharma Inc. is publicly traded on JPX under the ticker 4588.T.

Oncolys BioPharma Inc. is a biotechnology firm dedicated to the research, development, manufacturing, sales, and distribution of oncolytic viruses, pharmaceutical drugs, and diagnostic agents for tumors across Japan, other Asian regions, and the United States. Its robust pipeline features Telomelysin (OBP-301), an oncolytic adenovirus, currently in Phase II clinical trials for the treatment of gastric,...

Can you invest in Oncolys BioPharma Inc.?

Yes. Oncolys BioPharma Inc. is publicly traded on JPX under the ticker 4588.T.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Oncolys BioPharma Inc.

Detailed equity research is provided by MarketSnap.